4//SEC Filing
Dansky Ullmann Claudio 4
Accession 0001842952-24-000062
CIK 0001842952other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:18 PM ET
Size
5.7 KB
Accession
0001842952-24-000062
Insider Transaction Report
Form 4
Dansky Ullmann Claudio
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-08-01+202,170→ 202,170 totalExercise: $2.23Exp: 2034-07-31→ Common Stock (202,170 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on August 1, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0002030789
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:18 PM ET
- Size
- 5.7 KB